Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectives
Daniele Marinelli, Raffaele Giusti, Marco Mazzotta, Marco Filetti, Eriseld Krasniqi, Laura Pizzuti, Lorenza Landi, Federica Tomao, Federico Cappuzzo, Gennaro Ciliberto, Maddalena Barba, Patrizia Vici, Paolo Marchetti
Topics & Concepts
MedicineAdverse effectPalliative careImmune systemCancerDiseaseImmune checkpointIntensive care medicineOncologyInternal medicineImmunotherapyImmunologyNursingCancer Immunotherapy and BiomarkersNeuroendocrine Tumor Research AdvancesCancer, Stress, Anesthesia, and Immune Response